Support PenkeSR ONE CAPITAL MANAGEMENT, LP
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACLX.NASDAQ | Arcellx Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 4.34 | 39.29 | 2.3m | $20.9m | $182m |
| |||||||||||||
| CRSP.NASDAQ | Crispr Therapeutics AG | USA | Healthcare | Biotechnology | 2024-09-30 | 1.229 | 9.881 | 1m | $23.8m | $42.9m |
| |||||||||||||
| DSGN.NASDAQ | Design Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 11.53 | 7.04 | 6.5m | $29.1m | $41.4m |
| |||||||||||||
| EFTR.NASDAQ | Effector Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 10.56 | 2.063 | 6.8m | -$8.4m | $0.00 |
| |||||||||||||
| KALA.NASDAQ | Kala Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 9.624 | 0.507 | 443.6k | $657.5k | $2.7m |
| |||||||||||||
| NKTX.NASDAQ | Nkarta Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 4.724 | 3.021 | 3.3m | $19.5m | $7.8m |
| |||||||||||||
| SPRY.NASDAQ | Silverback Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 4.129 | 11.67 | 4m | $8.2m | $45.7m |
|
Trades
Buys
Report date: 2024-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| KALA.NASDAQ | 443.6k | - | 2.9m | 4-8 | $6.24 | 48.2% |
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CRSP.NASDAQ | 1m | - | 75m | 58-91 | $40.94 | -29.8% |
Report date: 2022-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| NKTX.NASDAQ | 1.3m | - | 17.4m | 8-20 | $2.35 | -68.9% |
Adds
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| NKTX.NASDAQ | 2m | 150.0 | 20.7m | 5-16 | $2.35 | -56.3% |
Report date: 2022-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| DSGN.NASDAQ | 900k | 16.0 | 12.1m | 7-17 | $6.35 | -8.5% |
Reduces
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACLX.NASDAQ | -800k | -25.4 | -50.7m | 51-75 | $77.58 | 51.0% |
Report date: 2023-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACLX.NASDAQ | -800k | -20.3 | -36m | 31-59 | $77.58 | 151.2% |
Report date: 2023-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACLX.NASDAQ | -1.5m | -28.2 | -59m | 27-49 | $77.58 | 184.4% |
Comments
How you think about this?